FINDING AND ROLE OF HEPATITIS C VIRUS IN THE PATHOGENESIS OF HODGKIN LYMPHOMA PATIENTS: A STUDY AT COMBINED MILITARY HOSPITAL PESHAWAR

Main Article Content

Sayyeda Aisha Bahar
Aqsa Amjad
Sana Arshad
Alina
Fazal Rabi
Kamran Saeed
Junaid Farman

Keywords

HCV, Hodgkin Lymphoma, pathogenesis, prevalence

Abstract

Background:  Hodgkin Lymphoma (HL) is a cancer of the lymphatic system; however, its cause is still unknown to date. Newer studies indicate that Hepatitis C Virus (HCV) may play a role in HL development.


Objectives:  The study aims are as follows: To establish the incidence of HCV in HL patients and examine its involvement in HL advancement.


Study design: A cross-sectional study.


Place and duration of study. Combined Military Hospital Peshawar from 05-Jan 2023 to 05-Jan 2024.


Methods:  Consequently, this study was cross-sectional, for which we recruited 200 patients with HL at CMH Peshawar. Information on HCV status included self-reports from patients’ medical records and blood tests. Data analysis was done using SPSS 24. 0 to analyze the HCV and HL relationship.


Results:  Among the 200 patients (mean age: The study participants’ mean age was 45 years with a standard deviation of 12 years; 20% of the participants were HCV positive. Results of the analysis of data revealed that there was a moderate relationship between HCV infection and HL at the P = 0. 03 level of significance.


Conclusion:  Based on this study, HCV infection has a significant positive relationship with HL and may therefore be involved in HL development. Preventive measures include the recommendation of routine hepatitis C virus screening in HL patients to enhance identification and treatment.

Abstract 193 | PDF Downloads 34

References

1. Young KH, Lee JY, Kim H, et al. (2006). Hepatitis C virus and lymphoproliferative disorders. World J Gastroenterol. 12(35):5635-5639.
2. Zignego AL, Ferri C, Giannelli F, et al. (2007). Prevalence of bcl-2 rearrangement in patients with chronic hepatitis C virus infection and lymphoproliferative disorders. Hepatology. 46(4):1030-1034.
3. Pileri SA, Uematsu Y, Campagnoli MF, et al. (1994). Binding of hepatitis C virus to CD81. Science. 282(5390):938-941.
4. Waheed Y, Shafi T, Safi SZ, et al. (2009). Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol. 15(45):5647-5653.
5. Idrees M, Riazuddin S. (2008). Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 8:69.
6. Montella M, Crispo A, Russo F, et al. (2004). HCV and risk of lymphomas: a case-control study. Br J Cancer. 90(3):341-344.
7. Montella M, Crispo A, Russo F, et al. (2004). HCV and risk of lymphomas: a case-control study. Br J Cancer. 90(3):341-344.
8. De Sanjose S, Benavente Y, Vajdic CM, et al. (2008). Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 6(4):451-458.
9. Zuckerman E, Zuckerman T, Levine AM, et al. (1997). Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 127(6):423-428.
10. Pozzato G, Mazzaro C, Crovatto M, et al. (1994). Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood. 84(9):3047-3053.
11. Dal Maso L, Polesel J, Serraino D, et al. (2009). Hepatitis C virus and risk of lymphomas: results of the multi-center Italian study. Int J Cancer. 124(8):1881-1886.
12. Vassilopoulos D, Calabrese LH. (2005). Hepatitis C virus infection and lymphoproliferative disorders: more than just an association? Cleve Clin J Med. 72(10):1055-1065.
13. Hermine O, Lefrere F, Bronowicki JP, et al. (2002). Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 347(2):89-94.
14. Lakhani MS, Quraishy MS, Khokhar N, et al. (2005). Treatment of hepatitis C virus infection: a review. Trop Gastroenterol. 26(3):117-125.
15. Engert A, Eichenauer DA, Dreyling M; ESMO Guidelines Working Group. (2010). Hodgkin’s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 21 Suppl 5
16. Ferenci P. (2007). Hepatitis C and lymphoma. J Clin Gastroenterol. 41(7):701-702.
17. Muhammad K, Ayub S, Haider I, et al. (2011). Hepatitis C virus-related chronic hepatitis in Pakistan: a study of HCV genotypes. J Gastroenterol Hepatol. 26(4):662-666.

Most read articles by the same author(s)